Metabolomic Profiling of Lungs from Mice Reveals the Variability of Metabolites in Pneumocystis Infection and the Metabolic Abnormalities in BAFF-R-Deficient Mice

References

• Grønseth S, Rogne T, Hannula R, Åsvold BO, Afset JE, Damås JK. Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway. BMC Infect Dis. 2021;21(1):659. doi:10.1186/s12879-021-06144-1
   PubMedGoogle Scholar
• Cillóniz C, Dominedò C, Álvarez-Martínez MJ, et al. Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther. 2019;17(10):787–801. doi:10.1080/14787210.2019.1671823
   PubMed Web of Science ®Google Scholar
• Roux A, Canet E, Valade S, et al. Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis. 2014;20(9):1490–1497. doi:10.3201/eid2009.131668
   PubMed Web of Science ®Google Scholar
• Enomoto T, Azuma A, Kohno A, et al. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection. Respirology. 2010;15(1):126–131. doi:10.1111/j.1440-1843.2009.01660.x
   PubMedGoogle Scholar
• Gingerich AD, Norris KA, Mousa JJ. Pneumocystis pneumonia: immunity, vaccines, and treatments. Pathogens. 2021;10(2). doi:10.3390/pathogens10020236
   PubMedGoogle Scholar
• Shellito J, Suzara VV, Blumenfeld W, Beck JM, Steger HJ, Ermak TH. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest. 1990;85(5):1686–1693. doi:10.1172/jci114621
   PubMedGoogle Scholar
• Beck JM, Warnock ML, Curtis JL, et al. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am J Respir Cell Mol Biol. 1991;5(2):186–197. doi:10.1165/ajrcmb/5.2.186
   PubMedGoogle Scholar
• Fishman JA. Pneumocystis jiroveci. Semin Respir Crit Care Med. 2020;41(1):141–157. doi:10.1055/s-0039-3399559
   PubMed Web of Science ®Google Scholar
• Garvy BA, Wiley JA, Gigliotti F, Harmsen AG. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect Immun. 1997;65(12):5052–5056. doi:10.1128/iai.65.12.5052-5056.1997
   PubMedGoogle Scholar
• Hu T, Takamoto M, Hida S, Tagawa Y, Sugane K. IFN-γ deficiency worsen Pneumocystis pneumonia with Th17 development in nude mice. Immunol Lett. 2009;127(1):55–59. doi:10.1016/j.imlet.2009.08.013
   PubMedGoogle Scholar
• Otieno-Odhiambo P, Wasserman S, Hoving JC. The contribution of host cells to pneumocystis immunity: an update. Pathogens. 2019;8(2):52. doi:10.3390/pathogens8020052
   PubMedGoogle Scholar
• Kolls JK. An emerging role of B cell immunity in susceptibility to pneumocystis pneumonia. Am J Respir Cell Mol Biol. 2017;56(3):279–280. doi:10.1165/rcmb.2016-0360ED
   PubMedGoogle Scholar
• Elsegeiny W, Eddens T, Chen K, Kolls JK, Deepe GS. Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia. Infect Immun. 2015;83(5):2043–2052. doi:10.1128/iai.03099-14
   PubMedGoogle Scholar
• Opata MM, Hollifield ML, Lund FE, et al. B lymphocytes are required during the early priming of CD4+ T cells for clearance of pneumocystis infection in mice. J Immunol. 2015;195(2):611–620. doi:10.4049/jimmunol.1500112
   PubMedGoogle Scholar
• Hu Y, Wang D, Zhai K, Tong Z. Transcriptomic analysis reveals significant B lymphocyte suppression in corticosteroid-treated hosts with pneumocystis pneumonia. Am J Respir Cell Mol Biol. 2017;56(3):322–331. doi:10.1165/rcmb.2015-0356OC
   PubMedGoogle Scholar
• Mackay F, Schneider P, Rennert P, Browning J. BAFF AND April: a tutorial on B cell survival. Annu Rev Immunol. 2003;21(1):231–264. doi:10.1146/annurev.immunol.21.120601.141152
   PubMedGoogle Scholar
• Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293(5537):2108–2111. doi:10.1126/science.1061965
   PubMed Web of Science ®Google Scholar
• Rong H-M, Li T, Zhang C, et al. IL-10-producing B cells regulate Th1/Th17-cell immune responses in Pneumocystis pneumonia. Am J Physiol Lung Cell Mol Physiol. 2019;316(1):L291–l301. doi:10.1152/ajplung.00210.2018
   PubMed Web of Science ®Google Scholar
• Jung J, Zeng H, Horng T. Metabolism as a guiding force for immunity. Nat Cell Biol. 2019;21(1):85–93. doi:10.1038/s41556-018-0217-x
   PubMed Web of Science ®Google Scholar
• Loftus RM, Finlay DK. Immunometabolism: cellular metabolism turns immune regulator. J Biol Chem. 2016;291(1):1–10. doi:10.1074/jbc.R115.693903
   PubMed Web of Science ®Google Scholar
• Rahman AN, Liu J, Mujib S, et al. Elevated glycolysis imparts functional ability to CD8(+) T cells in HIV infection. Life Sci Alliance. 2021;4(11). doi:10.26508/lsa.202101081
   PubMedGoogle Scholar
• Jing Y, Luo L, Chen Y, et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct Target Ther. 2021;6(1):345. doi:10.1038/s41392-021-00749-3
   PubMed Web of Science ®Google Scholar
• Gertsman I, Barshop BA. Promises and pitfalls of untargeted metabolomics. J Inherit Metab Dis. 2018;41(3):355–366. doi:10.1007/s10545-017-0130-7
   PubMed Web of Science ®Google Scholar
• Thomas T, Stefanoni D, Reisz JA, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5(14). doi:10.1172/jci.insight.140327
   Web of Science ®Google Scholar
• Ceballos FC, Virseda-Berdices A, Resino S, et al. Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation. Front Immunol. 2022;13:925558. doi:10.3389/fimmu.2022.925558
   PubMedGoogle Scholar
• Xu J, Zhou M, Luo P, et al. Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge. Clin Infect Dis. 2021;73(12):2228–2239. doi:10.1093/cid/ciab147
   PubMed Web of Science ®Google Scholar
• Antcliffe D, Jiménez B, Veselkov K, Holmes E, Gordon AC. Metabolic profiling in patients with pneumonia on intensive care. EBioMedicine. 2017;18:244–253. doi:10.1016/j.ebiom.2017.03.034
   PubMed Web of Science ®Google Scholar
• den Hartog I, Zwep LB, Vestjens SMT, et al. Metabolomic profiling of microbial disease etiology in community-acquired pneumonia. PLoS One. 2021;16(6):e0252378. doi:10.1371/journal.pone.0252378
   PubMedGoogle Scholar
• Schmidt SV, Schultze JL. New insights into IDO biology in bacterial and viral infections. Front Immunol. 2014;5:384. doi:10.3389/fimmu.2014.00384
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhu X, Zeng H. Fatty acid metabolism in adaptive immunity. Febs J. 2021. doi:10.1111/febs.16296
   Google Scholar
• Hussain H, Vutipongsatorn K, Jiménez B, Antcliffe DB. Patient stratification in sepsis: using metabolomics to detect clinical phenotypes, sub-phenotypes and therapeutic response. Metabolites. 2022;12(5). doi:10.3390/metabo12050376
   Google Scholar
• Li J, Luu LDW, Wang X, et al. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia. Emerg Microbes Infect. 2022;11(1):593–605. doi:10.1080/22221751.2022.2036582
   PubMed Web of Science ®Google Scholar
• Adu-Gyamfi CG, Snyman T, Hoffmann CJ, et al. Plasma indoleamine 2, 3-dioxygenase, a biomarker for tuberculosis in human immunodeficiency virus-infected patients. Clin Infect Dis. 2017;65(8):1356–1358. doi:10.1093/cid/cix550
   PubMed Web of Science ®Google Scholar
• Dewulf JP, Martin M, Marie S, et al. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci Rep. 2022;12(1):9959. doi:10.1038/s41598-022-14292-w
   PubMedGoogle Scholar
• Zardini Buzatto A, Sarkar I, van Drunen Littel-van den Hurk S, Li L. Comprehensive Lipidomic and metabolomic analysis for studying metabolic changes in lung tissue induced by a vaccine against respiratory syncytial virus. ACS Infect Dis. 2020;6(8):2130–2142. doi:10.1021/acsinfecdis.0c00210
   PubMedGoogle Scholar
• Zahoor I, Suhail H, Datta I, et al. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target. Proc Natl Acad Sci U S A. 2022;119(25):e2123265119. doi:10.1073/pnas.2123265119
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhang Z, Feng G, et al. Distinct lipid metabolic dysregulation in asymptomatic COVID-19. iScience. 2021;24(9):102974. doi:10.1016/j.isci.2021.102974
   PubMed Web of Science ®Google Scholar
• Weisel FJ, Mullett SJ, Elsner RA, et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat Immunol. 2020;21(3):331–342. doi:10.1038/s41590-020-0598-4
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhu X, Li C, et al. Stearoyl-CoA desaturase-mediated monounsaturated fatty acid availability supports humoral immunity. Cell Rep. 2021;34(1):108601. doi:10.1016/j.celrep.2020.108601
   PubMedGoogle Scholar
• Dagenais-Lussier X, Loucif H, Beji C, Telittchenko R, Routy JP, van Grevenynghe J. Latest developments in tryptophan metabolism: understanding its role in B cell immunity. Cytokine Growth Factor Rev. 2021;59:111–117. doi:10.1016/j.cytogfr.2021.02.003
   PubMedGoogle Scholar
• Grohmann U, Bronte V. Control of immune response by amino acid metabolism. Immunol Rev. 2010;236:243–264. doi:10.1111/j.1600-065X.2010.00915.x
   PubMedGoogle Scholar
• Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol. 2013;34(3):137–143. doi:10.1016/j.it.2012.10.001
   PubMed Web of Science ®Google Scholar
• Platten M, Nollen EAA, Röhrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18(5):379–401. doi:10.1038/s41573-019-0016-5
   PubMed Web of Science ®Google Scholar
• de Araújo EF, Loures FV, Preite NW, et al. AhR ligands modulate the differentiation of innate lymphoid cells and T Helper cell subsets that control the severity of a pulmonary fungal infection. Front Immunol. 2021;12:630938. doi:10.3389/fimmu.2021.630938
   PubMedGoogle Scholar
• Peyraud F, Guegan JP, Bodet D, Cousin S, Bessede A, Italiano A. Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives. Front Immunol. 2022;13:807271. doi:10.3389/fimmu.2022.807271
   PubMedGoogle Scholar
• Moffett JR, Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol. 2003;81(4):247–265. doi:10.1046/j.1440-1711.2003.t01-1-01177.x
   PubMed Web of Science ®Google Scholar
• Morris A, Norris KA. Colonization by Pneumocystis jirovecii and its role in disease. Clin Microbiol Rev. 2012;25(2):297–317. doi:10.1128/cmr.00013-12
   PubMed Web of Science ®Google Scholar
• Lund FE, Schuer K, Hollifield M, Randall TD, Garvy BA. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody. J Immunol. 2003;171(3):1423–1430. doi:10.4049/jimmunol.171.3.1423
   PubMedGoogle Scholar
• Ruan S, Cai Y, Ramsay AJ, Welsh DA, Norris K, Shellito JE. B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection. Vaccine. 2017;35(4):672–679. doi:10.1016/j.vaccine.2016.11.073
   PubMedGoogle Scholar
• Larange A, Cheroutre H. Retinoic acid and retinoic acid receptors as pleiotropic modulators of the immune system. Annu Rev Immunol. 2016;34:369–394. doi:10.1146/annurev-immunol-041015-055427
   PubMed Web of Science ®Google Scholar
• Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol. 2008;181(4):2277–2284. doi:10.4049/jimmunol.181.4.2277
   PubMed Web of Science ®Google Scholar
• Abdolahi M, Yavari P, Honarvar NM, Bitarafan S, Mahmoudi M, Saboor-Yaraghi AA. Molecular mechanisms of the action of vitamin A in Th17/Treg axis in multiple sclerosis. J Mol Neurosci. 2015;57(4):605–613. doi:10.1007/s12031-015-0643-1
   PubMed Web of Science ®Google Scholar
• Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007;317(5835):256–260. doi:10.1126/science.1145697
   PubMed Web of Science ®Google Scholar
• Hall JA, Cannons JL, Grainger JR, et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity. 2011;34(3):435–447. doi:10.1016/j.immuni.2011.03.003
   PubMed Web of Science ®Google Scholar
• Guo R, Xu X, Babcock SA, Zhang Y, Ren J. Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy. J Hepatol. 2015;62(3):647–656. doi:10.1016/j.jhep.2014.10.009
   PubMed Web of Science ®Google Scholar
• Fang R, Yang S, Gu X, Li C, Bi N, Wang HL. Early-life exposure to bisphenol A induces dysregulation of lipid homeostasis by the upregulation of SCD1 in male mice. Environ Pollut. 2022;304:119201. doi:10.1016/j.envpol.2022.119201
   PubMedGoogle Scholar
• Zhou J, Zhang N, Aldhahrani A, Soliman MM, Zhang L, Zhou F. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Front Immunol. 2022;13:956688. doi:10.3389/fimmu.2022.956688
   PubMed Web of Science ®Google Scholar